News

The Pharma Letter53m
Yeztugo holds potential to address key unmet needs for PrEP usage
Last week the US Food and Drug Administration approved Gilead Sciences Yeztugo (lenacapavir) for the prevention of HIV ...
The Observer3h
Ugandan firm to manufacture $28,000 HIV drug for just $50
In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing ...
FDA approves HIV drug based on University of Utah biochemist’s findings
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.
Safeguarding the windows to the soul
Stay informed on health matters with Zubeda Hamid's newsletter covering cataract surgeries, maternal health, and medical ...
Ahram Online21h
The world’s only twice-a-year shot to prevent HIV could stop transmission — if people can get it
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
Managed Healthcare Executive13h
Nearly a Quarter of HIV Patients in Los Angeles Homeless Within Last Year, Expert Says
There are a variety of reasons for this, including stigma, substance use disorders and trauma, according to Sonali Kulkarni, medical director in the Division of HIV and STD Programs at the Los Angeles ...
Wall Street Journal19h
Gilead’s HIV Breakthrough - WSJ - The Wall Street Journal
Lenacapavir was 100% effective in preventing HIV in one trial and 96% in the other. While Gilead’s pills are highly effective at preventing HIV, many people forget to take them daily.